# STIMPulseControl Ancillary Speech Study

> **NCT06561919** · NA · RECRUITING · sponsor: **Steffen Paschen** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease
- Impulse Control Disorder

## Interventions

- **PROCEDURE:** bilateral high frequency deep brain stimulation of the subthalamic neucleus combined with best medical treatment according to widely accepted expert consensus paper
- **DRUG:** best medical treatment for management of impulse control in Parkinson´s disease according to widely accepted expert consensus paper

## Key facts

- **NCT ID:** NCT06561919
- **Lead sponsor:** Steffen Paschen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-05
- **Primary completion:** 2027-07-15
- **Final completion:** 2028-07-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561919, "STIMPulseControl Ancillary Speech Study". Retrieved via MORVS 2026-10-14 from https://api.morvs.ai/clinical/NCT06561919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*